Get a glimpse into our company and investor data—powered by the PitchBook Platform
Early Stage VCLATEST DEAL TYPE
$4MLATEST DEAL AMOUNT
Owner and operator of a regenerative medicine company developing cell-based therapies. The company conducts testing and research of cell technology to derive human renal stem for the treatment of renal diseases.